E
Medicus Pharma Ltd. MDCX
$1.37 $0.032.24% NASDAQ
Recommendation
Prev Close
$1.34
Volume
331,429
Avg Vol (90D)
341,455
Market Cap
$33.65M
Dividend & Yield
--
52-Week Range
$1.28 - $8.94
P/E (TTM)
--
EPS (TTM)
-$2.17
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Small cap wrap: Medicus Pharma, OKYO, American Resources...
1/23/2026 - Proactive Investors - UK
Medicus Pharma marks Nasdaq milestone as it advances Phase 2 clinical programs
1/23/2026 - Proactive Investors - UK
Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony
1/23/2026 - GuruFocus
Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony
1/23/2026 - ACCESS Newswire
Medicus Pharma Lowers Teverelix Royalty Burden in Amended LifeArc License
1/22/2026 - TipRanks Financial Blog
Market movers: GE Aerospace, Mobileye, Medicus Pharma, P&G...
1/22/2026 - Proactive Investors - UK
Medicus Pharma marks Nasdaq anniversary with opening bell ceremony
1/22/2026 - Proactive Investors - UK
Medicus Pharma lowers royalty burden on prostate cancer drug Teverelix
1/22/2026 - Proactive Investors - UK
Medicus Pharma (MDCX) Reduces Royalty Rate in Teverelix Agreement
1/22/2026 - GuruFocus
Medicus Pharma Ltd. Announces Amendment to LifeArc License Improving Teverelix Long-Term Economic and Development Profile
1/22/2026 - Globe Newswire
Medicus Pharma marks one-year Nasdaq anniversary, advances Phase 2 therapeutics
1/20/2026 - Proactive Investors - UK
Medicus Pharma Ltd. Celebrates One Year on Nasdaq with Opening Bell Ceremony on January 22, 2026
1/20/2026 - GuruFocus
Medicus Pharma Ltd. Celebrates One Year on Nasdaq with Opening Bell Ceremony on January 22, 2026
1/20/2026 - Globe Newswire
Medicus Pharma to Present Women's Teverelix Data as SkinJect Phase 2 Approaches Database Lock
1/16/2026 - Proactive Investors - UK
Small cap wrap: Digi Power X, C3 Metals, Medicus Pharma, EDM Resources...
1/12/2026 - Proactive Investors - UK
Medicus Pharma advances Teverelix program, set to present Phase 1 data at AACE Annual Meeting
1/12/2026 - Proactive Investors - UK
Medicus Pharma Ltd. Studies Demonstrate Long-Acting Therapeutic Approach with Stable Bone ...
1/12/2026 - GuruFocus
Medicus Pharma announces clinical data on Teverelix
1/12/2026 - TipRanks Financial Blog
Medicus Pharma announces clinical data on Teverelix
1/12/2026 - The Fly
Medicus Pharma Ltd. Studies Demonstrate Long-Acting Therapeutic Approach with Stable Bone Turnover in Women
1/12/2026 - Globe Newswire
Medicus Pharma Ramps Up Partnering Push as Phase 2 SkinJect Data Nears
1/5/2026 - TipRanks Financial Blog
Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data ...
1/5/2026 - GuruFocus
Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data Approaches Readout and Partnering Readiness Accelerates
1/5/2026 - Globe Newswire
Medicus Pharma Launches At-the-Market Equity Offering Program
12/30/2025 - TipRanks Financial Blog
Medicus Pharma teams with Reliant AI for study push ICYMI
12/26/2025 - Proactive Investors - UK
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$2.32M
EBIT (TTM)
-$20.20M
Net Income (TTM)
-$34.49M
Balance Sheet
Total Assets (Q)
$9.98M
Total Debt (Q)
$7.05M
Total Liabilities (Q)
$10.78M
Book Value Per Share (Q)
-$0.0434
Cash Flow
Cash from Operations (TTM)
-$19.43M
Cash from Investing (TTM)
-$4.62M
Cash from Financing (TTM)
$27.41M
Net Change in Cash (TTM)
$3.36M
Filings
Filing Date
Friday, November 14, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Loading...
Beta
--
7-Day Total Return
-5.52%
30-Day Total Return
-36.57%
60-Day Total Return
-42.68%
90-Day Total Return
-44.76%
Year to Date Total Return
-14.38%
1-Year Total Return
-51.25%
2-Year Total Return
-66.59%
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Jan 21, 2026 - $1.28
52-week High
May 20, 2025 - $8.94
Valuation
Market Cap
$33.65M - Nano Cap
Enterprise Value
$32.15M
Price/Sales (TTM)
--
Price/Book (Q)
-30.88
Dividends and Shares
Shares Outstanding
18.63M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
medicuspharma.com
Phone Number
610 540 7515
Address
300 Conshohocken State Road
Conshohocken, PA 19428
Country
United States
Year Founded
2008
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in... more
NASDAQ 01/23/2026 4:00PM Eastern Quotes delayed